BlackRock Health Sciences Trust (BME) Balance Sheet

NYSE: BMEAssets, liabilities, debt and equity over 10 years.

BME balance sheet, 2025

December 31, 2025 · U.S. dollars

$570.1M assets = $1.8M liabilities + $568.3M equity

What it owns$570.1MCash & ST investments: $4.9M (0.9%)Receivables: $428,138 (0.1%)LT investments: $569.7M (99.9%)LT investments$569.7M · 100%=How it is financed$570.1MOther LT liabilities: $1.8M (0.3%)Shareholders’ equity: $568.3M (99.7%)Shareholders’ equity$568.3M · 100%

Both columns are drawn to the same scale: what BME owns equals what it owes plus shareholders’ equity. Hover a block for its value.

BME financial health

Debt / equity0.00
Low leverage · $0.00 of debt for each $1 of equity
Equity / assets99.7%
Equity-funded · of assets funded by shareholders
Cash / debt549.6%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

BME balance sheet trends, 2016–2025

BlackRock Health Sciences Trust balance sheet trends
MetricTrendThenLatestChange
Total assets$273.5M2016$570.1M2025+8.5%/yr
Total liabilities$2.8M2016$1.8M2025−4.8%/yr
Shareholders’ equity$270.7M2016$568.3M2025+8.6%/yr
Cash & short-term investments$8.9M2016$4.9M2025−6.4%/yr
Total debt$126,9012016$894,3322025+24.2%/yr
Net cash (debt)$8.8M2016$4.0M2025−$4.8M
Working capital−$976,2402016−$8.0M2023−$7.0M
Book value per share$31.302016$43.712025+3.8%/yr
Debt / equity0.0020160.0020250.00
Shares outstanding8.6M201613.0M2025+4.6%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

BME assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

BME liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

BME debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

BME balance sheet

BlackRock Health Sciences Trust annual balance sheet
2025202420232022202120202019201820172016
Assets
Cash & short-term investments$4.9M$26.6M$534$3,118$960$211,696$501,313$26.0M$14.4M$8.9M
Cash & equivalents$548$71,339$534$3,118$960$211,696$501,313$288$959$208,857
Short-term investments$4.9M$26.5M$31.4M$23.9M$27.8M$2.51B$3.7M$26.0M$14.4M$8.7M
Receivables$428,138$1.2M$1.6M$2.4M$3.2M$375,658$574,412$837,525$301,485$1.7M
Inventory$0$0$0$0$31.0M$0$4.7M$0$0$0
Other current assets$0$0$0$0$0$0$0$0$0$0
Total current assets$5.3M$26.6M−$37,840$3,118$960$409,348$1.1M$837,525$301,485$1.9M
Property, plant & equipment (net)$0$0$0$0$0$0$0$0$0$0
Goodwill & intangible assets$0$0$0$0$0$0$0$0$0$0
Long-term investments$569.7M$773.3M$594.4M$603.7M$645.5M$553.1M$452.2M$354.6M$334.2M$269.5M
Other non-current assets$0$0$1.7M$2.4M$3.3M$1.0M$1.28B$72,887$91,519$2.2M
Total assets$570.1M$774.6M$596.1M$606.1M$648.8M$554.6M$1.73B$355.5M$334.6M$273.5M
Liabilities
Accounts payable$211,959$493,107—$233,198$12.5M$114,211$1.5M$928,582$0$393,264
Short-term debt—$21,115$60,686$2,920$211,572$102,701$253,802$4,675$130,910$126,901
Deferred revenue———$230,278$12.3M$11,510—$923,907——
Total current liabilities——$8.0M$233,198$12.5M$8.6M$1.5M$928,582$2.8M$2.8M
Long-term debt$0$0$0$0$0$0$0$0$0$0
Lease obligations———————$0$0$0
Other long-term liabilities$1.8M$3.7M$8.0M$5.7M$10.6M$8.6M$6.6M$2.8M$10,013$2.8M
Total liabilities$1.8M$6.0M$8.0M$5.9M$23.0M$8.6M$93.5M$2.8M$2.8M$2.8M
Shareholders' equity
Common stock & paid-in capital$357.6M$942.1M$417.6M$424.3M$390.5M$339.1M$1.52B$253.0M$231.9M$211.7M
Retained earnings (deficit)$210.7M−$173.5M$170.5M$175.9M$235.3M$206.8M$117.3M$99.7M−$61,330$29,892
Treasury stock———————$0$0$0
Accumulated other comprehensive income$210.7M—$0$175.9M$235.3M$206.8M$154.6M$99.7M$100.0M$59.0M
Minority interest———————$0$0$0
Total shareholders' equity$568.3M$768.6M$588.1M$600.2M$625.8M$3.02B$1.64B$352.7M$331.9M$270.7M
Key figures
Total debt$894,332$299,173$60,686$2,920$211,572$102,701$253,802$4,675$130,910$126,901
Net cash (debt)$4.0M$26.3M−$60,152$198−$210,612$108,995$247,511$26.0M$14.3M$8.8M
Working capital——−$8.0M−$230,080−$12.5M−$8.2M−$444,954−$91,057−$2.5M−$976,240
Tangible book value$568.3M$768.6M$588.1M$600.2M$625.8M$3.02B$1.64B$352.7M$331.9M$270.7M
Book value per share$43.71$57.98$42.18$47.61———$40.55$37.34$31.30
Shares outstanding13.0M13.3M13.9M12.6M———8.7M8.9M8.6M
Current ratio——−0.000.010.000.050.710.900.110.66
Quick ratio——0.2010.170.250.070.7128.875.353.73
Debt / equity0.000.000.000.000.000.000.000.000.000.00
Equity / assets99.7%99.2%98.7%99.0%96.4%545.3%94.6%99.2%99.2%99.0%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed December 31, 2025); data from EODHD.

BME financial position

At the end of fiscal 2025 (December 31, 2025), BlackRock Health Sciences had total assets of $570.1 million (down 26.4% from a year earlier), total liabilities of $1.8 million and shareholders' equity of $568.3 million. It held $4.9 million in cash and short-term investments against $0.9 million of debt, a net cash position of $4.0 million. In the latest quarter (ended June 30, 2026) total assets were $574.6 million and equity $571.5 million.

Related: BME income statement, BME cash flow statement, BME key metrics. See the BME stock overview for the latest quote and news.

BME balance sheet FAQ

What are BlackRock Health Sciences's total assets?

BlackRock Health Sciences reported total assets of $570.1 million at the end of fiscal 2025 (December 31, 2025), compared with $774.6 million a year earlier.

How much debt does BlackRock Health Sciences have?

BlackRock Health Sciences had $0.9 million of total debt at the end of fiscal 2025, including short-term borrowings. Its debt-to-equity ratio was 0.00.

How much cash does BlackRock Health Sciences have?

BlackRock Health Sciences held $4.9 million in cash and short-term investments at the end of fiscal 2025; with $0.9 million of debt that is net cash of $4.0 million.

What is BlackRock Health Sciences's book value?

BlackRock Health Sciences's shareholders' equity (book value) was $568.3 million at the end of fiscal 2025, or $43.71 per share.

Asset Management: balance sheet